Insider Selling: Exponent (NASDAQ:EXPO) CEO Sells 4,930 Shares of Stock

Key Points

  • Catherine Corrigan, CEO of Exponent, Inc. (NASDAQ:EXPO), sold 4,930 shares at an average price of $66.82, totaling approximately $329,422.59, thus reducing her ownership by 5.62%.
  • Exponent's stock has shown a 1.5% increase recently and boasts a market capitalization of $3.45 billion, with a price-to-earnings ratio of 34.13.
  • The company declared a quarterly dividend of $0.30 per share, yielding 1.8%, and reported a year-over-year revenue growth of 7.3% in its latest earnings.

Exponent, Inc. (NASDAQ:EXPO - Get Free Report) CEO Catherine Corrigan sold 4,930 shares of Exponent stock in a transaction dated Wednesday, October 15th. The stock was sold at an average price of $66.82, for a total value of $329,422.60. Following the transaction, the chief executive officer directly owned 82,753 shares in the company, valued at approximately $5,529,555.46. The trade was a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Catherine Corrigan also recently made the following trade(s):

  • On Monday, September 15th, Catherine Corrigan sold 4,905 shares of Exponent stock. The stock was sold at an average price of $69.91, for a total value of $342,908.55.
  • On Thursday, August 14th, Catherine Corrigan sold 4,896 shares of Exponent stock. The shares were sold at an average price of $71.09, for a total value of $348,056.64.

Exponent Stock Up 1.5%

NASDAQ:EXPO opened at $68.25 on Friday. Exponent, Inc. has a 1-year low of $63.81 and a 1-year high of $114.99. The firm has a market capitalization of $3.45 billion, a price-to-earnings ratio of 34.13 and a beta of 0.91. The stock has a fifty day simple moving average of $69.63 and a 200 day simple moving average of $73.90.




Exponent (NASDAQ:EXPO - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.04. Exponent had a return on equity of 24.19% and a net margin of 18.35%.The business had revenue of $132.87 million during the quarter, compared to analyst estimates of $130.82 million. During the same quarter last year, the company posted $0.57 EPS. Exponent's revenue for the quarter was up 7.3% on a year-over-year basis. Equities analysts predict that Exponent, Inc. will post 1.98 earnings per share for the current year.

Exponent Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Friday, September 5th were given a dividend of $0.30 per share. The ex-dividend date was Friday, September 5th. This represents a $1.20 dividend on an annualized basis and a yield of 1.8%. Exponent's dividend payout ratio (DPR) is presently 60.00%.

Institutional Investors Weigh In On Exponent

Several institutional investors and hedge funds have recently added to or reduced their stakes in EXPO. Norges Bank acquired a new stake in Exponent in the 2nd quarter worth approximately $43,752,000. Millennium Management LLC increased its position in shares of Exponent by 543.1% during the first quarter. Millennium Management LLC now owns 305,230 shares of the business services provider's stock valued at $24,742,000 after purchasing an additional 257,766 shares during the period. First Trust Advisors LP bought a new stake in shares of Exponent during the second quarter valued at approximately $18,377,000. Cubist Systematic Strategies LLC bought a new stake in Exponent in the first quarter valued at $15,349,000. Finally, Geneva Capital Management LLC raised its stake in Exponent by 11.2% during the first quarter. Geneva Capital Management LLC now owns 1,745,828 shares of the business services provider's stock worth $141,517,000 after acquiring an additional 176,152 shares in the last quarter. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Weiss Ratings restated a "hold (c-)" rating on shares of Exponent in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Exponent presently has an average rating of "Hold".

View Our Latest Report on Exponent

About Exponent

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Read More

Insider Buying and Selling by Quarter for Exponent (NASDAQ:EXPO)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Exponent?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Exponent and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles